Beneficial Effects of Metformin on the Central Nervous System, with a Focus on Epilepsy and Lafora Disease.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
19 May 2021
Historique:
received: 20 04 2021
revised: 12 05 2021
accepted: 17 05 2021
entrez: 2 6 2021
pubmed: 3 6 2021
medline: 3 7 2021
Statut: epublish

Résumé

Metformin is a drug in the family of biguanide compounds that is widely used in the treatment of type 2 diabetes (T2D). Interestingly, the therapeutic potential of metformin expands its prescribed use as an anti-diabetic drug. In this sense, it has been described that metformin administration has beneficial effects on different neurological conditions. In this work, we review the beneficial effects of this drug as a neuroprotective agent in different neurological diseases, with a special focus on epileptic disorders and Lafora disease, a particular type of progressive myoclonus epilepsy. In addition, we review the different proposed mechanisms of action of metformin to understand its function at the neurological level.

Identifiants

pubmed: 34069559
pii: ijms22105351
doi: 10.3390/ijms22105351
pmc: PMC8160983
pii:
doi:

Substances chimiques

Hypoglycemic Agents 0
Neuroprotective Agents 0
Metformin 9100L32L2N

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NINDS NIH HHS
ID : P01 NS097197
Pays : United States
Organisme : Ministerio de Ciencia e Innovación
ID : Rti2018-095784b-100 SAF
Organisme : NIH HHS
ID : P01 NS097197
Pays : United States
Organisme : Ministerio de Ciencia e Innovación
ID : SAF2017-83151-R

Références

Nat Rev Neurol. 2020 Oct;16(10):529-546
pubmed: 32796930
FASEB J. 2016 Oct;30(10):3388-3399
pubmed: 27342766
Biochem Biophys Res Commun. 2004 May 28;318(2):372-80
pubmed: 15120611
Mol Neurobiol. 2020 Nov;57(11):4778-4789
pubmed: 32785826
Nat Rev Drug Discov. 2019 Jul;18(7):527-551
pubmed: 30867601
FEBS J. 2013 Jan;280(2):525-37
pubmed: 22364389
Chin Med J (Engl). 2014;127(9):1755-60
pubmed: 24791887
Arch Neurol. 1965 Feb;12:172-88
pubmed: 14237775
Adv Exp Med Biol. 2020;1260:319-332
pubmed: 32304040
Biochem Biophys Res Commun. 2014 Jun 13;448(4):414-7
pubmed: 24802403
Inflammopharmacology. 2021 Feb;29(1):137-151
pubmed: 33386490
Hum Mol Genet. 1999 Feb;8(2):345-52
pubmed: 9931343
Orphanet J Rare Dis. 2019 Jun 21;14(1):149
pubmed: 31227012
Ann Neurol. 1981 Jul;10(1):63-4
pubmed: 6791573
Int J Mol Sci. 2020 Jun 08;21(11):
pubmed: 32521797
Hum Mol Genet. 2000 Sep 22;9(15):2251-61
pubmed: 11001928
J Neuropathol Exp Neurol. 2012 May;71(5):413-21
pubmed: 22487859
Epilepsy Behav. 2020 Mar;104(Pt A):106893
pubmed: 32000097
Cells. 2018 Jul 26;7(8):
pubmed: 30050012
Curr Biol. 2007 Oct 9;17(19):1646-56
pubmed: 17900900
Arch Neurol. 1968 Jul;19(1):15-33
pubmed: 4175641
Pharmacol Res. 2020 Feb;152:104593
pubmed: 31843673
Metab Brain Dis. 2018 Feb;33(1):107-114
pubmed: 29080083
Biomed Khim. 2011 Nov-Dec;57(6):661-70
pubmed: 22359923
J Clin Neurophysiol. 1991 Jul;8(3):261-74
pubmed: 1918332
Neurology. 2017 Oct 31;89(18):1877-1885
pubmed: 28954880
Mol Neurobiol. 2020 Mar;57(3):1607-1621
pubmed: 31808062
Biochem Biophys Res Commun. 2021 Jan 1;534:908-913
pubmed: 33143871
Mol Aspects Med. 2005 Aug-Oct;26(4-5):256-67
pubmed: 16105679
J Biol Chem. 2010 Aug 13;285(33):25372-81
pubmed: 20538597
Mech Ageing Dev. 2020 Sep;190:111297
pubmed: 32610099
Nat Rev Neurosci. 2019 May;20(5):282-297
pubmed: 30792501
Free Radic Biol Med. 2015 Nov;88(Pt A):30-41
pubmed: 25680286
Autophagy. 2012 Apr;8(4):701-3
pubmed: 22361617
Neurology. 1970 Feb;20(2):160-76
pubmed: 4188951
Life Sci. 2020 Sep 15;257:118066
pubmed: 32652135
J Pharmacol Exp Ther. 2002 Aug;302(2):510-5
pubmed: 12130709
Autophagy. 2010 Oct;6(7):991-3
pubmed: 20818165
BMJ. 2005 Jun 4;330(7503):1304-5
pubmed: 15849206
Nat Rev Neurosci. 2018 Apr;19(4):235-249
pubmed: 29515192
Cell Mol Neurobiol. 2018 Oct;38(7):1425-1438
pubmed: 30132243
J Neurochem. 2016 Sep;138(5):653-93
pubmed: 27248001
Metabolism. 1994 May;43(5):647-54
pubmed: 8177055
Neuroscience. 2014 Sep 26;277:747-54
pubmed: 25108167
Proc Natl Acad Sci U S A. 2005 Jun 14;102(24):8501-6
pubmed: 15930137
Front Immunol. 2018 Jun 04;9:1236
pubmed: 29915588
Neuropsychopharmacology. 2009 Jun;34(7):1721-32
pubmed: 19145227
J Biol Chem. 2006 Oct 13;281(41):30412-8
pubmed: 16901901
Can J Physiol Pharmacol. 2019 Jan;97(1):37-46
pubmed: 30308130
Lancet Diabetes Endocrinol. 2017 Aug;5(8):597-609
pubmed: 28615149
Bosn J Basic Med Sci. 2018 Feb 20;18(1):49-54
pubmed: 28686850
J Biol Chem. 2011 Apr 29;286(17):14941-51
pubmed: 21372141
Cell Metab. 2020 Jul 7;32(1):44-55.e6
pubmed: 32402267
Epilepsia. 2017 Mar;58(3):467-475
pubmed: 28098937
Nat Med. 2004 Feb;10(2):148-54
pubmed: 14730359
Curr Pharm Des. 2020;26(39):5054-5066
pubmed: 32445451
Biochem J. 2015 Nov 1;471(3):307-22
pubmed: 26475449
Endocr Rev. 2021 Jan 28;42(1):77-96
pubmed: 32897388
Antioxidants (Basel). 2020 Apr 15;9(4):
pubmed: 32326494
Cell Metab. 2010 May 5;11(5):390-401
pubmed: 20444419
Hum Mol Genet. 2012 Apr 1;21(7):1521-33
pubmed: 22186026
Pediatr Neurol. 2001 Jul;25(1):21-9
pubmed: 11483392
Exp Cell Res. 2017 Mar 1;352(1):75-83
pubmed: 28159472
Nat Rev Immunol. 2018 Apr;18(4):225-242
pubmed: 29151590
BMJ Open Diabetes Res Care. 2015 Dec 11;3(1):e000090
pubmed: 26688733
Int J Mol Sci. 2020 Aug 19;21(17):
pubmed: 32825027
FEBS J. 2018 Jun;285(11):2071-2090
pubmed: 29645350
Drug Des Devel Ther. 2017 Aug 22;11:2421-2429
pubmed: 28860713
J Chem Neuroanat. 2020 Nov;109:101849
pubmed: 32679167
Epilepsy Res. 2014 Nov;108(9):1501-10
pubmed: 25246353
J Trace Elem Med Biol. 2013 Jan;27(1):31-9
pubmed: 22748695
Drug Metab Dispos. 2006 Mar;34(3):477-82
pubmed: 16381671
Neurology. 2005 Mar 22;64(6):982-6
pubmed: 15781812
Diabetologia. 2017 Sep;60(9):1662-1667
pubmed: 28770326
Front Neurosci. 2014 Sep 12;8:291
pubmed: 25309313
EMBO J. 2007 Jul 11;26(13):3169-79
pubmed: 17581637
PLoS One. 2016 Jul 28;11(7):e0159381
pubmed: 27467571
Hum Mol Genet. 2012 Jan 1;21(1):175-84
pubmed: 21965301
Heliyon. 2020 Apr 09;6(4):e03761
pubmed: 32382676
Pharmacol Res. 2016 May;107:333-343
pubmed: 27049136
J Biol Chem. 2004 May 14;279(20):20767-74
pubmed: 14985344
Hum Mol Genet. 1995 Sep;4(9):1657-63
pubmed: 8541857
Biochem J. 2012 Feb 1;441(3):763-87
pubmed: 22248338
Neurology. 2001 Jun 26;56(12):1739-45
pubmed: 11425943
Hum Mol Genet. 2002 May 15;11(11):1251-62
pubmed: 12019206
PLoS One. 2014 Dec 29;9(12):e115694
pubmed: 25546475
EMBO Mol Med. 2011 Nov;3(11):667-81
pubmed: 21882344
Nat Rev Neurol. 2019 Aug;15(8):459-472
pubmed: 31263255
Epilepsia. 1999;40 Suppl 3:12-6
pubmed: 10446745
J Neurochem. 2016 Oct;139 Suppl 2:115-125
pubmed: 26968531
Nat Rev Dis Primers. 2018 May 03;4:18024
pubmed: 29722352
Behav Neurol. 2019 Feb 4;2019:6234758
pubmed: 30863464
Mol Neurobiol. 2016 Mar;53(2):1296-1309
pubmed: 25627694
Front Endocrinol (Lausanne). 2018 Jul 19;9:400
pubmed: 30072954
Genes Dev. 2020 Oct 1;34(19-20):1330-1344
pubmed: 32912901
J Alzheimers Dis. 2015;44(1):43-8
pubmed: 25190626
Neuroreport. 2017 Mar 22;28(5):268-271
pubmed: 28181916
Brain. 1955 Sep;78(3):325-49
pubmed: 13269595
Ann Clin Transl Neurol. 2018 Dec 11;6(2):295-309
pubmed: 30847362
J Neuroimmunol. 2019 Jun 15;331:28-35
pubmed: 29566973
Cell Metab. 2014 Dec 2;20(6):953-66
pubmed: 25456737
Nat Genet. 1998 Oct;20(2):171-4
pubmed: 9771710
Pflugers Arch. 2020 Sep;472(9):1299-1343
pubmed: 32789766
Pharm Res. 2017 Dec;34(12):2614-2627
pubmed: 28589443
Mol Aspects Med. 2015 Dec;46:70-7
pubmed: 26344371
Biochem Biophys Res Commun. 2017 Mar 4;484(2):450-455
pubmed: 28137587
Expert Rev Neurother. 2021 Jan;21(1):45-63
pubmed: 33161784
Redox Biol. 2020 Jul;34:101517
pubmed: 32535544
Hum Mol Genet. 2010 Jul 15;19(14):2867-76
pubmed: 20453062
J Diabetes. 2011 Dec;3(4):320-7
pubmed: 21631893
Carbohydr Polym. 2020 Jul 15;240:116260
pubmed: 32475552
Nat Genet. 2003 Oct;35(2):125-7
pubmed: 12958597
Ann Neurol. 2010 Dec;68(6):925-33
pubmed: 21077101
J Parkinsons Dis. 2013;3(4):461-91
pubmed: 24252804
N Engl J Med. 1986 Jul 31;315(5):296-305
pubmed: 3088452
J Mol Med (Berl). 2011 Jul;89(7):667-76
pubmed: 21431325
Neuropharmacology. 2017 Oct;125:396-407
pubmed: 28807678
Exp Mol Med. 2019 Jun 5;51(6):1-16
pubmed: 31165723
Cell Metab. 2016 Jun 14;23(6):1060-1065
pubmed: 27304507
J Neurosci. 2004 Jan 14;24(2):479-87
pubmed: 14724246
Cell Rep. 2020 Sep 1;32(9):108092
pubmed: 32877674
Science. 2005 Dec 9;310(5754):1642-6
pubmed: 16308421
Brain Res Brain Res Rev. 1999 Apr;29(2-3):265-95
pubmed: 10209236
Circ Res. 2016 Aug 19;119(5):652-65
pubmed: 27418629
Am J Pathol. 2013 Aug;183(2):526-41
pubmed: 23759513
Life Sci. 2019 Sep 15;233:116686
pubmed: 31348946
J Biol Chem. 2000 Jan 7;275(1):223-8
pubmed: 10617608

Auteurs

Pascual Sanz (P)

Instituto de Biomedicina de Valencia (CSIC), Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Jaime Roig 11, 46010 Valencia, Spain.

José Maria Serratosa (JM)

IIS Fundación Jiménez Díaz, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28040 Madrid, Spain.

Marina P Sánchez (MP)

IIS Fundación Jiménez Díaz, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28040 Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH